Company intelligence / Profile preview

EpiSonica

Hsinchu City/East District, Taiwanepisonica.com ↗

Ownership: Private
Employees: ~78
Development stage: Other

Overview

EpiSonica is one of the world’s top three companies to commercialize MR-guided High Intensity Focused Ultrasound technology. Its ArcBlate 100M system enables non-invasive, incision-free soft tissue ablation with real-time thermal imaging. The iABUS system provides automated whole breast ultrasound tomography for improved breast cancer screening. Both products are commercially available and ready to meet global clinical demand.

Therapeutic areas: OncologyWomen's Health
Modalities: DeviceNon-pharmacological therapy (MR-guided High Intensity Focused Ultrasound)Imaging technology
Industry: Medical Imaging

Partnerships

No specific major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on EpiSonica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EpiSonica.

Explore the full profile